Updated
Updated · The Guardian · Sep 11
GLP-1 Jabs Cut Calories by Up to 40% but Can Regain 60% of Lost Weight
Updated
Updated · The Guardian · Sep 11

GLP-1 Jabs Cut Calories by Up to 40% but Can Regain 60% of Lost Weight

3 articles · Updated · The Guardian · Sep 11

Summary

  • GLP-1 drugs do not eliminate hunger, but they sharply reduce appetite and food intake—by up to 40% of calories—because they mimic a gut hormone far more powerfully and for much longer.
  • Gastrointestinal side effects are common, especially during dose increases, with nausea, constipation, diarrhoea, bloating and vomiting often worsened by dehydration as people eat and sometimes drink less.
  • Up to 40% of weight lost on the drugs may come from lean mass, experts said, making protein intake and resistance training essential to limit muscle loss and poorer body composition.
  • About 60% of lost weight can return after stopping treatment, and one Oxford study found many users regain their original weight within two years, reinforcing that obesity drugs may need long-term use.
  • Experts also said the drugs are not for casual aesthetic use, 5%-20% of users may be non-responders, and evidence for benefits beyond weight loss—from mental health to cancer risk—is still limited or evolving.

Insights

If patients regain most of their weight after stopping GLP-1 drugs, are we creating a lifelong chemical dependency for weight management?
Could the rapid muscle loss and malnutrition hidden behind GLP-1 weight-loss miracles trigger an entirely new public health crisis?
With stronger triple-agonist obesity drugs arriving by 2027, how far can we biologically hack our metabolism before side effects become unmanageable?